Figure 1From: Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancerKaplan-Meier analyses of survival according to clinical and pathologic stages.Back to article page